Chronic Low Back Pain Seminar Patient Engagement

Slides:



Advertisements
Similar presentations
Introduction of California Headache and Pain Center Chong-hao Zhao, MD, PhD American Board of Psychiatry and Neurology, Neurology Subspecialty Board of.
Advertisements

JSNA Schizophrenia progress report Martina Pickin Locum Consultant in Public Health.
Pain Management Coding
Chiropractic Physicians Filling the Role of Non-surgical Spine Specialists A West Hartford Group Presentation.
COPS Providing Quality Service in a Cost Effective Way.
Low back pain Implementing NICE guidance 2009 NICE clinical guideline 88.
What is Pain? Conceptualizing Chronic Pain Tissue Disruption Functional Disruption Environment and Treatment Expression of Pain.
What type of information do service providers/ commissioners need? – good quality evidence to underpin service delivery/commissioning Screening Matched.
Low Back Pain and Lumbar Disc Disease
The importance of musculoskeletal health problems Up to 30% of all GP consultations relate to musculoskeletal problems, and this area accounts for a £230m.
SPINAL STENOSIS Jung U. Yoo, M.D. Professor and Chairman Department of Orthopedics and Rehabiliatation Oregon Health and Science University.
脊 骨 健 康 護 理 專 家 The Experts in Spinal Health Care.
Chronic Pain A Review of the Literature. Meade Study: BMJ 1990 A British ten year study concluded that chiropractic treatment was significantly more effective,
Low Back Pain. What is low back pain? Pain in the low back.
NICE short clinical guideline (SCG) development: An overview of the role of the information specialist Lynda Ayiku and Hanna Lewin (NICE Information Specialists)
Knee Replacement Surgery Evaluating Rehabilitation Management Strategies Dr Marlene Fransen.
Dr.Moallemy Lumbar Facet Pain (pain Originating from the Lumbar Facet Joints)
1 RADIOFREQUENCY NERVE LESIONING Dr Zbigniew M Kirkor Pain Clinic, Princess Alexandra Hospital Harlow, Essex, UK 1.
Practice Parameter: Use of Epidural Steroid Injections to Treat Radicular Lumbosacral Pain (An Evidence-Based Review) American Academy of Neurology (AAN)
T&O. ICATS Worcestershire an outlier on spend on orthopedics in the West Midlands ICATS now saves 2 Million (includes total cost of extra physio and the.
Pain Management Service Royal Bolton Hospital Dr Ian Waite Consultant in Anaesthesia and Pain Medicine.
Attention Deficit Hyperactivity Disorder (ADHD) Dr Sooraj Natarajan Clinical Director for Children and Maternity Basildon and Brentwood Clinical Commissioning.
Chiropractic & Pain Case Studies
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Voluntary Sector Care Partnerships
Immediate solutions to address demand and capacity pressures in Hospital Eye Services David Geddes Head of Primary Care Commissioning.
Transforming Outpatients Project
Joint Commissioning-or just how do we turn the system around?
MEP Interest Group on Brain, Mind and Pain
New Advance in Back Pain Treatment: Stem Cell Therapy
Right Care Programme in West Essex
Developing MSK Services in Southern Derbyshire
Future Medical Cost Projections
Hillingdon CCG CCG 360o stakeholder survey 2014 Summary report.
The DEPression in Visual Impairment Trial:
Spine Symposium 2017.
Psychiatry Higher Training
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
Making NICE research nicer Involving patients, carers and the public
Person Centred Care in NHS Wales
EVALUATION AND TREATMENT OF ACUTE LOW BACK PAIN
24/04/2012 NICE guidance and best practice in psychological care for “bipolar disorder” Dr Graeme Reid, Consultant Clinical Psychologist, Step 5, Central.
SEND Single Route of Redress - National Trial
Hepatitis B and C management pathways in prison:
Dr James Carlton, Medical Adviser
Community Rheumatology
When Interventional Injections and Nerve Blocks Can Help
Specialised Commissioning Improving specialised services for severe intestinal failure adult patients What will this mean for you?
NICE -The End of Life Care (Service Delivery) Guideline for adults in the last year of life. NICE’s aim is to improve outcomes for people who use the.
Gary Jenkins Director, Regional Services 27 September 2016
A catalogue of material to support CCGs, GP practices and others to undertake initiatives to support STOMP
Living With and Beyond Cancer
Dr Peter Groves MD FRCP Consultant Cardiologist
The NHS.
Nuzhat Ali, National Lead MSK Health
Non-Pharmacological Therapies, Chronic Pain and Opioid Addictions
Dry Eyes – Lubricant Eye Drops
The MSK-HQ Developing a generic Musculoskeletal Patient Reported Outcome Measure Policy & Public Affairs Team, Arthritis Research UK e.
Radiofrequency denervation for chronic low back pain
The North of England Regional Back Pain Pathway
Harrow CCG CCG 360o stakeholder survey 2014 Summary report.
Central and North West London NHS Foundation Trust
Diagnosis of disease M2/D2
Moving Forward Together Programme Overview
Berkshire West Public Engagement Event
Caring, Learning and Growing
Working Together Across Cheshire
Working Together Across Cheshire
Self Management for Secondary Care 19 June 2019 Welcome to
Realistic Prescribing Pathways
Presentation transcript:

Chronic Low Back Pain Seminar Patient Engagement NHS North West London CCGs 6th February 2017

Aims and Objectives Welcome and introductions Why are we here? To hear patient views as CCGs plan to adopt NICE guidance To raise awareness of changes proposed To invite you to the NWL stakeholder session on the 21st of February 2017

Meet the Team June Farquharson - Associate Director, NWL IFR team Dr Lily Wong - General Practitioner and Medical Adviser IFR/PPwT/NWL Policy Development Team Facilitators

World Health Organisation Low back pain The lifetime prevalence of non-specific (common) low back pain is estimated at 60% to 70% Low back pain is the most common cause of disability in young adults, with more than 100 million workdays lost per year. Annual total costs due to low back pain are estimated at £12.3 billion; At present low back pain is treated mainly with analgesics. The causes of lower back pain are rarely addressed. Alternative treatments include physical therapy, rehabilitation and spinal manipulation. Disc surgery remains the last option, but the outcomes are disappointing. £1.6 billion for direct healthcare resources, £1.6 billion related to informal care and £9.1 billion through production loss (indirect costs) due to morbidity. World Health Organisation

Why we need a new Low Back Pain Policy New NICE guidance, published in November 2016 It no longer recommends some routine treatments on the basis that they are of limited clinical benefit We’re drafting a new policy and we want your input

What is NICE? The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.

NICE Recommendations Invasive procedures currently provided in secondary care lack clinical effectiveness and should not be routinely commissioned. More holistic management of patients with chronic low back pain, rather than referral to secondary care where interventions are largely ineffective. These interventions are no longer recommended: Acupuncture Discectomy Interlaminar, transformational caudal epidural injection for patients with radicular pain Therapeutic facet joint injection Thermal frequency denervation of lumbar & cervical facet joints

Draft plans NWL CCGs do NOT commission the following for non radicular spinal pain Facet Joint injections Therapeutic Medial Branch Blocks (cervical, thoracic, lumbar) Intradiscal therapy Prolotherapy Trigger point injections with any agent, including botox Epidural steroid injections (non-radicular pain) Spinal injections not specifically covered above Acupuncture for back pain (with or without radicular symptoms) and osteoarthritis   NWL CCGs fund Radiofrequency Denervation for chronic low back pain when: All conservative measures have been tried (see NICE pathway) A diagnostic medial branch block at a single facet joint level provides >80% improvement in pain for the duration of the block The patient has moderate or severe levels of localised back pain (rated as 5 or more on a visual analogue scale, or equivalent) at time of referral Retreatment is not routinely funded unless treatment has provided at least 15months of symptom relief Do not offer imaging for people with low back pain with specific facet join pain as a prerequisite for radiofrequency denervation (NICE NG59)

Draft plans NWL CCGs fund Caudal, Interlaminar and Transforaminal (nerve root) epidural injections for acute radicular pain and lateral canal stenosis only   NWL CCGs will NOT fund the following surgical procedures for nonspecific low back pain. (Specific causes of LBP e.g spondylithesis, scoliosis or severe structural disease are out of scope and not covered by this policy): Spinal fusion, except as part of a randomised controlled trial (RCT) Lumbar disc replacement NWL CCGs recommend that imaging for chronic low back pain should not routinely be offered in a non-specialist setting for people with low back pain with or without sciatica.

Evidence base Acupuncture was not shown to be any more effective than sham acupuncture Facet joint injections: no short term clinical effect versus saline, uncertainty of clinically important differences versus active comparators Medial branch blocks: no clinically important difference Trigger point injections: Steroid + local anaesth: no short term clinical effect. Botulinum toxin: insufficient evidence Epidural steroid in non specific low back pain: no clinically important difference

Why should we do this and what are the implications? A greater emphasis on clinically effective treatments for patients who have chronic low back pain Better use of limited NHS resources and funds redirected to services which can provide effective treatments Treatments that have been shown to have little clinical effectiveness will not be funded

Key points to remember NWL CCGs would like to use the evidence to develop our policy NWL CCGs want to provide effective treatments for their patients We want your views – No decisions have been made yet If you don’t think we should follow the NICE evidence, tell us why.

Break Out Sessions We would like your views and thoughts What three key thoughts do you have? Suggest questions such as Do you want clarity on what this means for other services? Is there something about a service such as acupuncture that you don’t get with others and needs to be kept? If you don’t think we should follow the evidence, please say so. Also look at what is good about the service you currently receive and tell us what we need to reassure you about. How would we communicate this change to fellow patients Would you like to talk

Timelines Today 21st February 2017 14th March 2017 June/July 2017 Patient Engagement Wider stakeholder Engagement NWL Policy Development Group NWL Collaboration Board for sign off Today 21st February 2017 14th March 2017 June/July 2017

Want to carry on the conversation? Save the date! We are holding a stakeholder workshop to discuss the proposed policy 21st February 2017, 0930-1300, Hellenic Centre, 16-18 Paddington St, Marylebone, London W1U 5AS We’d really like people to hear your views first hand so please volunteer to feedback

References NICE 2016 Low back pain and sciatica https://www.nice.org.uk/guidance/ng59 NICE 2016

Any questions?